Trials / Completed
CompletedNCT01209624
Observational Study of the Long-term Effect of Latanoprost in Normal Tension Glaucoma
Prospective, Observational Study to Investigate the Long-term Effect of Xalatan® on Intraocular Pressure (IOP) and on Maintenance of Visual Field in Patients With Normal Tension Glaucoma (NTG)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 902 (actual)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the long-term efficacy and safety of latanoprost monotherapy in patients with normal tension glaucoma (NTG) using a prospective, observational design. Visits were scheduled at 6-month intervals for 24 months. Intraocular pressure (IOP), optic nerve head findings, visual field status, and adverse events were recorded.
Conditions
Timeline
- Start date
- 2006-08-01
- Primary completion
- 2009-09-01
- Completion
- 2009-09-01
- First posted
- 2010-09-27
- Last updated
- 2021-02-26
- Results posted
- 2010-10-26
Source: ClinicalTrials.gov record NCT01209624. Inclusion in this directory is not an endorsement.